HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘The Party Is Over': Green Claims Requirements Among Many Regulatory Changes Coming To EU Cosmetics

Executive Summary

Biorius CEO Frédéric Lebreux provided updates on EU Green Deal initiatives including revision of the Cosmetic Products Regulation, as well as regulations in development for green claims and ecodesign, at the Independent Beauty Association’s virtual Technical/Regulatory Forum.

You may also be interested in...



L’Oreal Joins Heavyweights Tackling Sustainable Surfactants With Geno Biotech

L’Oreal, Kao and Unilever have partnered with Genomatica, Inc. (Geno) to develop sustainable surfactants by replacing feedstocks such as palm oil and fossil fuels with biotech alternatives.

EU Starts On Proposal For Tackling ‘Most Harmful’ Chemicals Under Revised Cosmetics Reg

The European Commission is preparing a legal proposal to revise the Cosmetic Products Regulation in line with Green Deal objectives, including the phasing out of chemicals deemed “most harmful." Cosmetics Europe director-general John Chave discusses the problematic approach, possible impacts, and the bizarre and unintended results it could produce.

EU’s Planned Revision Of Cosmetics Regulation Makes For Uneasy Global Industry

To cosmetics industry stakeholders, the EU’s talk of instituting a generic risk management approach to eliminate “most hazardous” chemicals spells wholesale adoption of the precautionary principle, the disposal of exposure and risk considerations, and, ultimately, increased cosmetic ingredient restrictions and bans without proportionate human health benefits.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153446

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel